Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Gross Margin (2016 - 2025)

Historic Gross Margin for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 70.79%.

  • Healthequity's Gross Margin rose 52100.0% to 70.79% in Q4 2025 from the same period last year, while for Oct 2025 it was 67.72%, marking a year-over-year increase of 23900.0%. This contributed to the annual value of 64.78% for FY2025, which is 24900.0% up from last year.
  • Per Healthequity's latest filing, its Gross Margin stood at 70.79% for Q4 2025, which was up 52100.0% from 71.38% recorded in Q3 2025.
  • Healthequity's Gross Margin's 5-year high stood at 71.38% during Q3 2025, with a 5-year trough of 51.95% in Q1 2022.
  • Its 5-year average for Gross Margin is 61.26%, with a median of 60.68% in 2023.
  • In the last 5 years, Healthequity's Gross Margin tumbled by -28700bps in 2021 and then soared by 64800bps in 2023.
  • Quarter analysis of 5 years shows Healthequity's Gross Margin stood at 57.55% in 2021, then grew by 2bps to 58.92% in 2022, then increased by 8bps to 63.87% in 2023, then grew by 3bps to 65.58% in 2024, then grew by 8bps to 70.79% in 2025.
  • Its last three reported values are 70.79% in Q4 2025, 71.38% for Q3 2025, and 67.8% during Q2 2025.